Firmagon Uniunea Europeană - română - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostate neoplasme - terapia endocrină - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Degarelix Accord Uniunea Europeană - română - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostate neoplasme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Turanabol comprimate 10 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

turanabol comprimate 10 mg

balkan pharmaceuticals srl, sc - chlorodehydromethyltestosteronum - comprimate - 10 mg

BioR 10 mg supozitoare Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bior 10 mg supozitoare

ficotehfarm srl - soluţie alcoolică inventia se refera - supozitoare - 10 mg